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Abstract 
Background  
The Government of Rwanda considers the private sector to play an important role in 
supporting provision of strategic national investments through Public-Private Partnerships 
(PPPs).  
Objective 
This study aims to describe the various aspects of PPPs in Health Supply Chain Management 
(HSCM) in Rwanda.  
Methods 
A questionnaire was used to collect data from health professionals and individuals familiar 
with HSCM Public-Private Partnerships for this descriptive, cross-sectional and quantitative 
study.  
Results  
The PPP interventional areas used in HSCM in Rwanda were namely supply of commodities 
(99%), delivered health Information Technology (IT) supplies and equipment (operate) (53%), 
finance (52%), and maintenance area (40%). The main challenges were limited conversation 
and absence of formal platforms for public and private engagement (83.7%) and complex 
procurement requirements for medical products and equipment by public institutions 
(73.3%). The strategies to improve the PPPs in HSCM were effective coordination of PPPs 
(93.3%) and improved dialogue and formal platforms (90.6%) 
Conclusion 
These findings indicated that private sector through PPPs plays an important role in HSCM 
in Rwanda. The engagement of the private sector can increase the financial support in terms 
of financing HSCM activities like supply of health commodities and equipment.  
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Private sector engagement has gained an 
important momentum over the last two 
decades. The 2030 Agenda for 
Sustainable Development serves as a 
blueprint for global development and 
catalyse the private sector investment 
across various sectors.[1,2] This calls for 
the immediate mechanisms to enhance 
the partnership between the 
Government and private sector 
including civil society, businesses and 
others to achieve Sustainable 
Development Goals (SDGs).[3]  
 
The Government of Rwanda (GoR) takes 
into consideration the important role of 
the private sector (both for-profit and 
not-for-profit) in supporting 
improvement in the delivery of strategic 
national investments through Public-
Private Partnerships (PPPs) and 
strengthen of the health system.[2] The 
GoR is committed to promote Public-
Private Partnership (PPPs) which could 
help to increase the participation of 
investment in health infrastructure and 
services.[4] 
 
Different countries have deployed some 
efforts to strengthen the engagement of 
the private sector in health with the 
overall aim of relieving the burden on the 
public sector, leveraging on financial 
resources and capacities from the 
private sector and reduce inequalities in 
access and use of healthcare services.[5] 
The GoR considers access to affordable 
medicines and medical devices a priority 
for its citizens. The Fourth Health Sector 
Strategic Plan (HSSPIV) stipulates that 
essential medicines and health 
equipment need to be available all the 
times in appropriate quality and at a 
reasonable price for individuals and 
households.[1] 
Public-Private Partnerships (PPPs) are 
defined as a long-term contract between 
a private company and a government 
entity, for providing a public asset or 
service, in which the private company 
bears significant risk and management 
responsibility, and remuneration, is 
linked to performance.[3,6] 
Internationally, Governments from both 
developed and developing countries 
consider the Public-Private Partnerships 
(PPPs) as one of the important 
mechanisms to expand access to quality 
health services, enhance the health 
financing system and leverage 
managerial capacity from the private 
sectors.[2] For the present health sector 
to be increasingly successful and 
sustainable in a declining external 
financing and donation, at that point the 
private sector needs to assume a crucial 
role in connecting the financing gap. 
This increased interests in PPPs can be 
attributed to several reasons including 
the escalating costs of providing health 
care services, increases in chronic 
diseases, inadequate public health 
infrastructure, medicine shortages, 
limited capacity of the public sector to 
meet the health needs of the population 
and rapidly changing and advancing 
medical technologies.[7]  
However, according to Fourth Health 
Sector Strategic Plan (HSSPIV), there 
was outstanding challenges including 
the important external financing of the 
sector, which was not sustainable. There 
was also an outstanding challenge of 
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limited capacity in terms of internal 
revenues to address issues related to 
supply chain capabilities at different 
levels.[1] There was also an issue where 
private sector in supply chain 
management was not involved in solving 
the aforementioned challenges. 
 
It was thus crucial to conduct the study 
to describe various aspects regarding 
the PPPs in Health Supply Chain 
Management in Rwanda and came up 
with the findings and recommendations 
that may help decision makers and 
stakeholders to streamline the 
implementation of PPPs towards 
effective financing in health supply 
chain management in Rwanda. 
Specifically, this study intended to 
describe different areas of PPPs current 
in Health Supply Chain Management 
(HSCM) in Rwanda; determine benefits 
of PPPs and available opportunities in 
HSCM in Rwanda; identify challenges 
that hinder private sector engagement in 
HSCM in Rwanda; and identify 
strategies to improve PPPs in HSCM in 
Rwanda. [1, 3, 4, 8] 
 
Methods 
Study design, site, and population 
The study used a descriptive, cross-
sectional design with a quantitative 
approach. The study participants were 
103 experts, health professionals and 
individuals with good 
understanding/familiar with PPPs from 
institutions namely the Ministry of 
Health (MOH), Rwanda Biomedical 
Centre (RBC) divisions, district 
pharmacies and private wholesale 
pharmacies. The 103 experts were 
identified based on their routine 
involvement in the Health Supply Chain 
Management related to procurement, 
distribution, financing, inventory 
management, storage and use of medical 
products. The experts selected to 
participate in the study were contacted 
and given the questionnaires for filling. 
However, 15 did not agree to participate 
and 13 people were not found as they 
were absent during data collection.     
 
Sample size and sampling technique 
The sample size of this study was 75 
respondents from relevant government 
and non-government actors including 
faith based organizations and private 
pharmacies. A purposive sampling was 
used to get the right respondents 
knowledgeable with PPPs in HSCM. The 
sample size was determined using the 
below formula Slovin's formula n= 
N/(1+Ne^2), where n was the sample 
size, N was the population size and e 
was the margin of error chosen by the 
researcher n=103/ (1+103*0.05^2) 
=~75  
Data collection tools 
A semi-structured questionnaire (shown 
in Appendix 1) was used to answer the 
questions related to the study objectives. 
The questionnaire had part on 
demographic features of interviewee and 
main questions related to Public-Private 
Partnerships (PPPS) in HSCM. 
Data collection procedure 
The suitable method of data collection 
used for this study was the 
questionnaire. After consenting, the 
questionnaires were given in person by 
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the researcher to respondents who read 
and understood the questions and wrote 
down appropriately the responses in the 
space provided in the questionnaire. The 
questions were organised according to 
research topic to ensure that the 
research questions or objectives were 
covered throughout the questionnaire. 
Data analysis 
The data entry was done using Microsoft 
Excel. These data were exported into 
Statistical Package for the Social 
Sciences (SPSS) for further analysis. The 
analysis plan included descriptive 
analysis, univariate and Bivariate 
analysis  
Ethical consideration 
The ethical consideration was sought to 
ensure that the study conducted did not 
cause any harm to participants. The 
approval clearances were given by the 
University of Rwanda, Institutional 
Review Board (IRB) and National Health 
Research Committee (NHRC). The 
ethical clearances were: Approval Notice: 
No 351/CMHS IRB/2019 issued on 19th 
July 2019 from University of Rwanda, 
Institutional Review Board (IRB) and 
Ref: NHRC/2019/PROT/045 issued on 
6th August 2019 from National Health 
Research Committee. 
Results  
Sociodemographic characteristics of 
respondents  
Most of the study respondents worked in 
public institutions and represented 
about 56 %.  Among the respondents, 
majority were male 67 (89.3%) while 
female represented only 10.7% (Table 1). 
Regarding the age group, more than half 
respondents (57%) were aged between 
35- 45 years while those aged between 
25-35 years represented about 37.3%. 
only 5.3% of respondents were above 45 
years old. Regarding the education 
attainment, the majority were bachelor’s 
holders (73.6%) and the rest were 
master’s holders. About the work 
experience, more than a half (53.3%) of 
the respondents had work experience of 
between 5-10 years in those companies 
and this demonstrated the richness of 
the information that was provided by 
those respondents. 
Table 1. Sociodemographic characteristics of respondents  
Characteristics  
Private Public Total  
Number  Percentage Number  Percentage Number  Percentage 
Sex  
Female 3 4.0 5 6.7 8 10.7 
Male  30 40.0 37 49.3 67 89.3 
Age  
 25- 35 years  17 22.7 11 14.7 28 37.3 
 35- 45 years  15 20 28 37.3 43 57.3 
 >45 years  1 1.3 3 4 4 5.3 
Education Levels 
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Degree (A0)  23 30.7 32 42.7 55 73.3 
Masters  10 13.3 10 13.3 20 26.7 
Work experience  
1-5 years  7 9.3 1 1.3 8 10.7 
5-10 years  16 21.3 24 32 40 53.3 
> 10 years  10 13.3 17 22.7 27 36.0 
Areas of PPPs in Health Supply Chain 
Management in Rwanda 
Overall, the delivery area of health 
commodities was the most reported area 
of PPP in HSCM at about 99% (Figure 1). 
The delivery of IT supplies and 
equipment area (operate) represented 
53% of the respondents. The finance 
area in HSCM in Rwanda was reported 
by respondents at 52%. The 
maintenance area represented 40% of 
the respondents. In designing of 
projects, this was reported to be 35% 
whereas for build area, construction of 
health facilities/buildings was the least 
reported by respondents with 31%. The 
figure below shows the details. 
Figure 1. Distribution of interventional areas of PPPs in Health Supply Chain 
Management in Rwanda. 
The benefits of the PPPs in Health 
Supply Chain in Rwanda 
This study found that 90.6% of the 
respondents reported that PPPs have 
resulted to the availability of medicines, 
medical devices and medical equipment 
(health commodities) whereas 82% of 
respondents reported transportation 
services as also the main contribution of 
PPPs in HSCM in Rwanda (Table 2). 
Similarly, almost 80 % of respondents 
reported that the PPPs have improved 
the cost effectiveness in treatment of 
diseases (e.g. availability of hepatitis C 
medicines at a lower cost).  More than 














































respondents agreed that PPPs have 
resulted to the improved financing of 
health supply chain projects, while 
(62.6%) of the total number of the study 
interviewed reported that PPPs in HSCM 
contributed to availability of health 
infrastructure. The table below indicates 
the views of participants in relation to 
the benefits in HSCM. 
 
 
Table 2. The benefits of the PPPs in health supply chain management in Rwanda 





















Financing of health supply chain projects  
1 0 0.0 5 6.7 3 4.0  
2 0 0.0 5 6.7 3 4.0  
3 13 17.3 9 12.0 11 14.7  
4 39 52.0 33 44.0 35 46.7 77.4 
5 22 29.3 23 30.7 23 30.7 
Availability of health commodities  
2 0 0.0 2 2.7 1 1.3  
3 5 6.7 7 9.3 6 8.0  
4 11 14.7 20 26.7 16 21.3 90.6 
5 59 78.7 46 61.3 52 69.3 
Health infrastructure  
1 7 9.0 1 1.3 3 5.0  
2 0 0.0 7 9.3 4 5.0  
3 20 27.0 22 29.3 21 28.0  
4 28 36.0 23 30.7 25 33.3 62.6 
5 20 27.0 22 29.3 22 29.3 
Cost effectiveness to the patients   
1 2 3 0 0 1 1  
2 4 9 4 5 5 7  
3 0 0 16 21 9 12  
4 32 42 29 38 30 40 80 
5 33 45 27 36 30 40 
Transportation services  
1 2 3 1 2 2 3  
2 5 6 4 5 4 5  
3 9 12 7 10 8 11  
4 32 42 43 57 38 51 82 
5 27 36 20 26 23 31 
Note: We have combined the 4th and 5th score rate to inform the decision
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Opportunities available for PPPs in 
Health Supply Chain Management in 
Rwanda 
More than 94.7% reported that the 
political will from the government is the 
enabling factor for implementation of 
PPPs in HSCM. The majority of the 
respondents (92%), also reported that 
the existence of active private 
pharmaceutical institutions is key for 
the effective running of PPPs in HSCM. 
Four fifth of the respondents indicated 
that a well-structure health supply 
chain (82.7%) and Universal health 
coverage (80%) are crucial for the 
implementation of PPPs in HSCM. The 
least reported opportunity was the e-
health systems (e-procurement, online 
importation) representing 76%.  
Companies/institutions have 
practice guidelines on PPP 
implementation 
Most of the respondents (79%) indicated 
that they did not have guidelines or 
procedures in place for managing 
implementation of PPPs (Fig. 2). Only 
21% of the respondents showed that 
they did possess guidelines on the PPPs 
implementation. The figure below shows 
the findings on guidelines availability for 
PPPs implementation 
 
Figure 2. Institutions that have practice guidelines on PPP implementation 
PPP projects/activities in health 
supply chain management meet their 
expected results 
The majority of the respondents 
indicated that the PPPs projects in 
HSCM met their expected results during 
implementation and this represented 
72% of the respondents (Figure 3). 
 
 
Figure 3. PPP projects in health 































Existence of challenges encountered 
when implementing PPPs in health 
supply chain management (HSCM) in 
Rwanda 
Most of the respondents representing 95 
% agreed that there were impediments in 
the execution of PPPs Projects. The 
remaining 5% of the respondents replied 
that there were no challenges 
encountered during the implementation 
of PPPs in health supply chain 
management (HSCM) in Rwanda. 
Challenges that hinder private sector 
engagement in HSCM in Rwanda 
The respondents showed that there was 
a challenge of insufficient information 
sharing between public and private and 
this was representing 83.7%. Another 
major issue was complex procurement 
requirements for medical products and 
equipment by public institutions in 
private sector representing 73.3% of the 
respondents. Ineffective 
management/coordination and clear 
roles and responsibilities between public 
institutions and key stakeholders was 
also another issue that was reported by 
67.6% of the respondents. The 
challenges of contracts including delay 
payment, clauses favouring one part etc. 
was pointed out to be hindering the 
implementation of PPPs in HSCM 
representing 64.8% of the respondents. 
The least issue reported was lack of 
regulations/laws about PPPs in HSCM 
representing 58.1 % of the respondents.  
 
Measures that can be put in place to 
improve PPPs in health supply chain 
management in Rwanda 
The majority of the respondents (93.3%) 
reported that for PPPs in HSCM to be 
more effective, there should effective 
management/coordination of such 
PPPs. Again there should be high 
improved dialogue and formal platforms 
as reported by 90.6% of the 
respondents. More than four fifth 
reported that enhancing transparencies 
from all partners involved in PPPs would 
lead to effective implementation of PPPs 
and this was reported by 89.3% of the 
respondents.  The respondents also 
indicated that trust between parties in 
PPPs (84.0%) and appropriate risk 
allocation (financial) (81.3%) will lead to 
improved performance of PPPs in HSCM. 
The respondents also mentioned that 
there should be laws and regulations 
about PPPs in HSCM that are flexible to 
all parties and make known by 
concerned people. This was reported by 
65.4% of the respondents. Finally, the 
issue of contracts was indicated to be 
solved by having well prepared contract 
document with equally shared risks and 
this was reported by respondents 
representing 64.0%. 
 
Experiences shared about PPPs in 
HSCM IN Rwanda 
The respondents shared their 
experiences or testimonies about PPPs 
in HSCM. Most of them highlighted PPPs 
in supplying hepatitis C treatment 
medicines; PPPs in supplying Non 
Communicable Diseases medicines, & 
PPPs with Abbott in distribution of 
laboratory reagents for Viral Load, 
Biochemistry &Haematology that 
contributed a lot for health public. 
Others said leasing of medical 
equipment where health facilities do 
purchase only the reagents.  
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Others said that successfully 
implemented collaboration between 
District Pharmacies and private health 
posts by putting them under the same 
conditions as other public health 
facilities for example during active 
distribution where they transport health 
commodities for them together with 
those of the health centres they belong 
to. PPPs in regards with Health Supply 
Chain Management is a key approach to 
increase supply chain performance 
through readily health commodity 
availability, accessibility and 
affordability to the public. 
Discussion  
Different Interventional Areas of PPPs 
in Health Supply Chain Management 
in Rwanda 
This study investigated the different 
interventional areas of PPPs existing in 
HSCM in Rwanda. These PPP areas 
include Finance, Maintain, Operate & 
Deliver, Design and Build. The most 
predominant PPP area was, the delivery 
of health commodities, representing 99 
%.  Other areas were the supply of IT 
supplies and equipment (operate) (53%), 
the finance area (52%) the maintenance 
area (40%), designing of projects (35%) 
and build area, construction of health 
facilities/buildings (31%). 
 
Similar findings were seen in the study 
that was conducted in Canada by David 
Barrows et al., where it was found that 
PPPs were involved in designing and 
building areas of hospitals and the 
delivery of non-clinical services which 
was reported at 61%.[9] However, these 
results are different from those of this 
study in relation to areas like financing, 
delivery and maintenance as these were 
not discovered in PPPs of that study. 
 
The results of this study were also 
similar to those of the study that was 
conducted by Global Health Group from 
University of California, San Francisco 
in partnership with PwC Global 
Healthcare in as far as Public-Private 
Partnerships (PPPs) in health was 
concerned.[6] It was found that the 
private institutions had the mainly in 
charge for; providing financial support 
or co-financing the capital cost or 
project, maintenance of buildings and 
equipment required to offer health 
supply chain management services, 
organization and provision of specific 
HSCM services; delivery of equipment, 
the design of the facilities, building of 
new, or renovation of existing, buildings. 
[6] In this study the private companies 
involved in the maintenance and 
building of health facilities like health 
posts where the Ministry of Health 
worked in collaboration with 
development partners like One Family 
Health Project.  
Benefits of PPPs in HSCM in Rwanda 
From the results of this study, the 
respondents revealed that there were 
benefits of using PPPs in HSCM in 
Rwanda. The benefits that the 
respondents indicated were availability 
of health commodities (90.6%), 
transportation services involved in 
HSCM (82%), cost effectiveness to 
patients in relation to their treatment 
(80%), financing of health supply chain 
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projects (77.4%), and Health 
infrastructure (62.6%). The Government 
of Rwanda has benefited from HSCM 
PPPs where cost of treatment for some 
health conditions has been reduced. 
These include treatment of Hepatitis C 
condition where the private sector plays 
a role in availability, accessibility and 
affordability of the medicines to treat 
such condition. The private sector also 
plays a role in financing of HSCM 
activities organized by the public health 
institutions by supplying medicines or 
providing funds for such activities. 
Private pharmacies have also seen in 
distribution and transportation of 
medicines to district pharmacies free of 
charge in implementing the HSCM PPPs. 
 
Similar study that was conducted by 
Caines et al., in Sri Lanka, Uganda and 
Zambia, found that the involvement of 
various pharmaceutical companies 
through PPPs aided to effective 
medicines availability very significantly 
in those three concerned study 
countries.[10]  In Zambia, there was also 
expansion of access to malaria drug 
Coartem® at an affordable price via 
partnership with private pharmacies 
and retail outlets that were selected.[10] 
 
In Rwanda for instance, the PPPs have 
led to cost effectiveness to patients. The 
patients at first could not afford the 
hepatitis C medicines. They were 
expensive and not accessible. With 
PPPs, the Hepatitis C medicines were 
made accessible, available and 
affordable to the patients and hence real 
sense of cost effectiveness to patients as 
a result of PPPs. 
This was also in line with the GOR vision 
2020 where PPPs contributed to the 
economy scale of the country by 
providing quality infrastructure, 
services delivery and pharmaceutical 
products, and helped in achieving GOR’s 
goals/objectives in Vision 2020, Vision 
2050 and the Economic Development 
and Poverty Reduction Strategy 
(EDPRS).[4] 
 
The GOR also has done tremendous 
efforts in implementing PPPs in HSCM 
especially in the availability of health 
commodities at affordable cost for 
instance hepatitis C health commodities 
and these available in selected wholesale 
pharmacy (ies). There has been also 
signing agreement between GOR with 
private companies in construction of 
health facilities for instance, health 
posts that have been build country wide 
especially in remote areas.[11] This is 
also in line with the results of this study. 
Opportunities available for PPPs in 
Health Supply Chain Management in 
Rwanda 
This study found out that there were 
opportunities available for the 
implementation of PPPs in HSCM in 
Rwanda. These include the political 
representing 94.7% of respondents, 
active private pharmaceutical sector 
(92%), a well-structure health supply 
chain (82.7%), of a well-functioning e-
health systems (e.g. e-procurement, 
online importation) and high enrolment 
and health insurance schemes, 
representing 76% and 80% respectively. 
The GOR is dedicated to offer a smooth 
environment for the investment in all 
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sectors including HSCM. This has led to 
private pharmacies to frequently 
opening and operating and hence able to 
contribute in PPPs of HSCM.   
 
The study conducted by Global Health 
Group at the University of California, in 
relation to Public-Private Partnerships 
(PPPs) in health care, it came up with 
some similar opportunities for PPPs in 
HSCM. In that study, it was found that 
the key enabling conditions or 
opportunities for PPPs in healthcare 
were; political will, legislative and 
regulatory framework, transparency, 
public sector capacity, contract 
completeness, flexibility and governance 
and broad stakeholder engagement.[6]  
Company/institution have practice 
guidelines on PPP implementation 
The results of this study revealed that 
from all respondents, the availability of 
guidelines on the PPPs implementation 
was at 21%. Most of the respondents 
(79%) replied that they had no 
guidelines on how to deal with PPPs 
HSCM projects. This is an issue as the 
implementation of the PPPs would be 
difficult and reach the expected targets. 
 
Similarly, in the study that was 
conducted in Canada by David Barrows 
et al., which found out that the majority 
of respondents did not have a working 




PPP projects/activities in health 
supply chain management meet their 
expected results 
The findings of this study found that the 
implementation of PPPs projects in 
HSCM that met their expected results as 
indicated by 72% of the respondents. 
This is an indication that the PPPs in 
HSCM are crucial to public at large. 
 
In the study that was conducted in 
South Africa, it was found that the 
respondents the private sector gave 
security in that they executed the project 
effectively and efficiently within cost, on 
time, and to the specifications. However, 
the government can open doors, provide 
legislation, get things passed, but they 
rarely can execute.[12] 
Existence of challenges encountered 
when implementing PPPs in health 
supply chain management (HSCM) in 
Rwanda 
The findings of this study came up with 
95 % of the respondents indicating that 
there were challenges in the 
implementation of PPPs Projects. 
 According to the study that was 
conducted in Canada by Barrows et al., 
it was found that PPP arrangements 
used in resulted in issues/challenges 
especially in the delivery of care by 58% 
and contracts by 24%.[9]  
Furthermore, and similarly in the study 
that was conducted in Iran by Ehsan 
Zarei et al., it was found that there were 
challenges that faced PPPs in health 
sector including the complexity, low-
quality evaluation and irregular 
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supervision, lack of transparency, and 
inadequate coordination.[13] 
Challenges that hinder private sector 
engagement in HSCM in Rwanda 
The findings of this study indicated that 
there were challenges in the 
implementation of PPPs projects in 
HSCM. These were limited dialogue and 
no formal platforms or systems for 
public and private engagement 
(Information Sharing) (83.7%), complex 
procurement requirements for medical 
Products and equipment by public 
institutions (73.3%), ineffective 
coordination and clarity of roles and 
responsibilities between Public 
institutions and key stakeholders 
(67.6%), contracting issues (64.8%) and 
lack of regulations/laws about PPPs in 
HSCM (58.1 %). These challenges bring 
attention that need to be considered so 
that they can be mitigated and hence 
have smooth PPPs in HSCM. Thus the 
recommendation from this study 
included to promote and enhance 
significant engagement of all private 
companies in the development of HSCM 
PPP policies, laws, regulations and 
guidelines so as to guarantee awareness, 
ownership of the PPPs. Another 
recommendation would be to strengthen 
the coordination and collaboration 
between the public and private sectors 
in HSCM on regular basis so that private 
sector is participative in health sector 
activities especially financing. 
 
In the study that was conducted in 
Germany, it was found that PPPs 
projects faced challenges namely; poor 
management of the PPPs, conflicts of 
interests between the public and the 
private sectors, accountability, risk 
management, costs of regulation and 
transaction costs.[14] The results of that 
study were difference to this one except 
for poor management of PPPs that was 
also identified in this study. The 
recommendation here would be to 
establish and discover the possibility for 
privatization of medicines procurement 
and distribution both national and 
internationally by public institutions. 
In the study that was conducted by UN 
Commissions globally on PPPs in Health 
supply chain, the challenges were lack of 
control over resources, delayed decision 
making by public sector, contracting 
issues, payment terms and information 
sharing issues.[15] These were somehow 
similar to those of this study like issues 
of contracting, and information sharing. 
The recommendation would be to 
potentially initiate and enhance private 
sector contributions especially financial 
support in HSCM PPPs. 
Measures that can be put in place to 
improve PPPs in health supply chain 
management in Rwanda 
The findings of this study showed that 
there are measures/strategies to 
improve the PPPs in HSCM and these 
were to enhance effective 
management/coordination of PPPs 
(93.3%), to improved dialogue and 
formal platforms (90.6%), to foster 
transparencies from all partners 
(89.3%), trust between parties in PPPs 
(84%), appropriate risk allocation 
(financial) (81.3%), put and make aware 
laws and regulations about PPPs in 
HSCM (65.33%) and well prepared 
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contract document (64%). Though there 
were challenges in implementing PPPs in 
HSCM, the respondents gave their views 
on the measures that could be taken to 
mitigate the existing challenges. 
 
Similar findings to this study were also 
found in the study that was conducted 
by United Nations (UN) Commissions 
globally on PPPs in Health supply chain, 
where it was found that the strategies or 
measures to improve PPPs in HSCM 
were to start with realistic vision of what 
can be attained, build partnership based 
on the mutual trust, foster transparency 
from all parties, demonstrate 
commitment from PPPs, learn from other 
sectors, advocate for changes.[15] 
Limitations of the study 
The study was not conducted in both 
public and private institutions that were 
not involved in the Public-Private 
Partnerships in Health Supply Chain 
Management.  It was also not conducted 
in health facilities like hospitals, health 
centres, clinics, dispensaries, health 
posts and community because of their 
limited involvement in PPP in HSCM. 
Conclusion 
From the study results, it was found 
that private sector through PPPs plays 
an important role in the Health Supply 
Chain Management in Rwanda. The 
engagement of the private sector can 
increase the financial support in terms 
of financing the projects of HSCM, 
delivery or supply of health commodities 
and equipment. Through PPPs in HSCM, 
there has been also effective and 
affordable cost of treatment to patients, 
availability of medicines and 
accessibility of health services. Thus the 
GOR should keep on use of PPPs when 
appropriate.  
 
However, there were challenges that 
hinder the implementation of PPPs in 
HSCM which should be resolved for the 
benefit of the concerned parties and the 
public in general.  
 
Therefore, with PPPs in HSCM, there 
may be sustainable financial support, 
affordability of treatment costs to 
patients and availability of medicines 
and equipment in public. This calls for 
the public decision makers in different 
levels to greatly and always consider the 
involvement of private sector in HSCM.  
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APPENDIX 1: QUESTIONNAIRE FOR THE STUDY 
 
"The use of Public-Private Partnerships in Health Supply Chain Management in 
Rwanda" 
 
Name and contact information of principal investigator 
BYOMUHANGI EVARISTE, UNIVERSITY OF RWANDA, CMHS 
Tel: +250788681650, Email: byomevariste@gmail.com 
 
The following questionnaire will be completed with voluntary participation noted as 
consent.  
 
PART I: Demographic Features of Interviewee 





1. Type of organization: Public □ 
                                Private □ 
2. Please indicate your age:  
a) Below 25 years □ 
b) Between 25- 35 years □ 
c) Between 35- 45 years □ 
d) Above 45 years □ 
3. What is your level of education? 
a) Certificate (A2) □ 
b) Advance diploma (A1) □ 
c) Degree (A0) □ 
d) Masters  □ 
e) Other (specify) ………….. 
4. What is your working experience? 
a) Less than a year □ 
b) Between 1-5 years □ 
c) Between 5-10 years □ 
d) Above 10 years □ 
 
PART 2: Public-Private Partnerships (PPPS) In HSCM 
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Description Yes No 
Finance  Financing or co–financing of the project   
Deliver  Delivery and management of Health 
commodities 
  
Operate  Supply of applicable equipment and IT    
Design  
 
Design of the project, including design of 
the infrastructure and care delivery model 
  
Build   Construction or renovation of facilities 




Maintenance of hard infrastructure 





6. What are the benefits of the PPPs in health supply chain management in 
Rwanda? 
 
Benefits of PPPs 











 1  
Strongly 
disagree 
Financing of health supply 
chain projects (purchase of 
medicines)      
Availability of health 
commodities      
Health infrastructure 
(Accessibility of health 
services  to public           
Cost effectiveness to the 
patients         
Transportation services (eg. 
of health commodities)        
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7. What are your company’s contributions PPPs in health supply chain 
management in Rwanda? 
Company contributions to PPPs 
YES NO 
Health Financing support 
   
Availability of health commodities 
  
Health infrastructure (Accessibility of health services  
to public)  
    
Cost effectiveness to the patients 
    
Transportation services (eg. of health commodities)   
  
Other (Please specify): ………………………… 
  
 
8. What are the opportunities available for PPPs in Health Supply Chain Management 
in Rwanda? 
Opportunities available for 
PPPs 











 1  
Strongly 
disagree 
Political will           
Well-structured health supply 
chain          
Active private pharmaceutical 
sector            
Universal health coverage           
e-health systems (e-
procurement, online 
importation etc)       
Other (Please specify)…………           
 




10. Do PPP projects in health supply chain management end up meeting their 










11. Are there any challenges encountered when implementing PPPs in health supply 
chain management (HSCM) in Rwanda? 
□Yes 
□ No 
12. If yes, what are the challenges that hinder private sector engagement in 
HSCM in Rwanda? 
Challenges 














 1  
Strongly 
disagree 
Lack of Regulations/laws about 
PPPs in HSCM           
Limited dialogue and no formal 
platforms or systems for public and 
private engagement (Information 
Sharing)          
Ineffective coordination and clarity 
of roles and responsibilities between 
Public institutions and key 
stakeholders           
Contracting Issues          
Complex procurement requirements 
for medical Products and equipment 
by public institutions          
 
13. What measures that can be put in place to improve PPPs in health supply 
chain management in Rwanda? 
Measures that can be put in 
place to improve PPPs in HSCM 










 1  
Strongly 
disagree 
Foster transparency from all 
partners.           
Appropriate risk allocation 
(financial)             
Effective 
management/coordination of 
PPPs           
Trust between parties in PPPs      
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Well prepared contract document      
Put and make aware laws and 
regulations about PPPs in HSCM      
Improved dialogue and formal 
platforms           
 
14. Any experience/testimony with PPP health supply chain management 




I thank you so much for your kind participation in this study! 
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